Kazakhstan’s first domestically developed cancer drug will not be ready by the end of 2025, despite earlier assurances from government officials.
Set deadline
In March, Science and Higher Education Minister Sayasat Nurbek said the country would complete development and registration of the drug by year’s end. At the time, he said the medication had successfully passed the first phase of clinical trials and was being tested on multiple types of cancer.
According to Nurbek, tumors in patients had shrunk by an average of 30%, some patients had gone into remission, and officials were planning a separate press conference...